Jim Simons Portfolio March 2026 - Top Holdings & 13F Analysis
Analysis of Jim Simons's March 2026 13F portfolio with 20 holdings worth $64.5B. +17.1% 1-year return.
In This Article
- 1.About Jim Simons and RENAISSANCE TECHNOLOGIES LLC
- 2.Jim Simons's Top 10 Holdings — March 2026
- 3.Portfolio Strategy & Concentration Analysis
- 4.Best Performing Holdings in Jim Simons's Portfolio
- 5.Understanding Jim Simons's 13F Filing
- 6.How Retail Investors Can Use This Information
- 7.Other Top Investors to Follow
Portfolio Value
$64.46B
Total Holdings
20
1-Year Return
+17.1%
About Jim Simons and RENAISSANCE TECHNOLOGIES LLC
Jim Simons is the portfolio manager at RENAISSANCE TECHNOLOGIES LLC, one of the closely tracked institutional investors in our database. Every quarter, institutional investment managers with over $100 million in assets under management are required to file a 13F report with the SEC, disclosing their long equity positions. These filings give retail investors a rare window into how professional money managers are allocating capital.
As of March 2026, Jim Simons's 13F portfolio contains 20 positions with a disclosed market value of approximately $64.46 billion. This analysis covers their top holdings, recent portfolio changes, and key investment themes.
Over the past year, Jim Simons's portfolio has delivered a +17.1% return, significantly outperforming the broader market.
Jim Simons's Top 10 Holdings — March 2026
The following table shows Jim Simons's largest disclosed stock positions ranked by portfolio weight as reported in the most recent 13F filing. These represent the highest-conviction bets in the portfolio:
| # | Company | Ticker | Portfolio Weight | Market Value | Performance |
|---|---|---|---|---|---|
| 1 |
SINOVAC BIOTECH LTD
|
SINX | 0.00% | $0.0M | — |
| 2 |
PALANTIR TECHNOLOGIES INC
|
PLTR | 242.57% | $1563.6M | -2.6% |
| 3 |
UNITED THERAPEUTICS CORP DEL
|
UTHR | 144.32% | $930.3M | +16.2% |
| 4 |
MICRON TECHNOLOGY INC
ADDED
|
MU | 133.32% | $859.4M | +70.6% |
| 5 |
KINROSS GOLD CORP
|
KGC | 109.11% | $703.3M | +13.3% |
| 6 |
VERISIGN INC
|
VRSN | 104.75% | $675.2M | -13.1% |
| 7 |
NETFLIX INC
ADDED
|
NFLX | 104.41% | $673.0M | -92.2% |
| 8 |
TESLA INC
ADDED
|
TSLA | 95.03% | $612.6M | +1.1% |
| 9 |
EXELIXIS INC
|
EXEL | 94.61% | $609.9M | +6.1% |
| 10 |
COSTCO WHSL CORP NEW
ADDED
|
COST | 92.71% | $597.6M | -6.8% |
Data sourced from SEC 13F filings. Holdings reflect disclosed long equity positions. Options and short positions may not be reflected.
Portfolio Strategy & Concentration Analysis
Jim Simons's investment approach reflects a highly concentrated portfolio strategy. The top position, SINOVAC BIOTECH LTD (SINX), represents 0.0% of the total portfolio, while the top 5 holdings collectively account for 629.3% of disclosed assets.
The portfolio saw no new positions this period, suggesting Jim Simons is maintaining existing conviction levels and managing existing holdings rather than initiating new bets.
Additionally, Jim Simons increased stakes in 11 existing positions, a sign of growing conviction in those holdings.
Best Performing Holdings in Jim Simons's Portfolio
Based on available performance data, the following positions have been the strongest contributors to Jim Simons's portfolio returns:
Understanding Jim Simons's 13F Filing
A 13F filing is a quarterly disclosure required by the SEC for institutional investment managers that exercise discretion over $100 million or more in qualifying securities. These filings must be submitted within 45 days of the end of each calendar quarter.
Important caveats about 13F data:
- Data is delayed by up to 45 days from the end of the quarter
- Only long equity positions are disclosed — short positions are not required
- Options positions are disclosed separately and may indicate hedging strategies
- The portfolio may have changed significantly since the filing date
- Not all positions need to be disclosed (some confidentiality provisions exist)
Despite these limitations, 13F filings remain one of the best public sources of information on how professional investors are positioning their portfolios. Use this data as one input among many, alongside your own research and risk tolerance.
How Retail Investors Can Use This Information
Following institutional 13F filings like Jim Simons's can provide valuable investment insights — but it's important to use this information correctly:
- Identify high-conviction ideas: Large positions and new entries signal where managers have the strongest conviction.
- Spot emerging themes: Cross-portfolio analysis reveals sector rotations and macro themes playing out across institutional money.
- Validate your own research: If an investor you respect owns a stock you're analyzing, that can reinforce your thesis.
- Track changes over time: Watching a manager increase or decrease positions over multiple quarters shows conviction trends.
- Don't blindly copy trades: Remember that institutional investors have different time horizons, risk tolerances, and information than retail investors.
You can track Jim Simons's complete portfolio in real-time on Insider Edges, including historical holdings, sector breakdown, and performance data.
Other Top Investors to Follow
If you track Jim Simons's portfolio, you may also be interested in following these other closely watched institutional investors:
Track Jim Simons's Portfolio in Real-Time
Get notified when new 13F filings drop, access the complete holdings breakdown, and track portfolio changes over time with Insider Edges.
Track Jim Simons's Full Portfolio
View all holdings, recent trades, and performance data for RENAISSANCE TECHNOLOGIES LLC
Get Monthly Hedge Fund Alerts
Be the first to know when new 13F filings drop and get monthly portfolio analysis straight to your inbox.
Related Articles
Analysis of Yijun Liu's March 2026 13F portfolio with 6 holdings worth $0.8B. +43.7% 1-year return.
Mar 14, 2026
Analysis of William Harnisch's March 2026 13F portfolio with 15 holdings worth $4.2B. +51.7% 1-year return.
Mar 14, 2026
Analysis of Warren Buffett's March 2026 13F portfolio with 20 holdings worth $274.2B. +9.8% 1-year return.
Mar 14, 2026
Analysis of Tweedy Browne's March 2026 13F portfolio with 20 holdings worth $1.2B. +25.5% 1-year return.
Mar 14, 2026